BioCentury
ARTICLE | Clinical News

Epizyme, GlaxoSmithKline preclinical data

January 19, 2015 8:00 AM UTC

In mouse xenograft models of MCL, twice-daily doses of 25, 50, 100 and 200 mg/kg EPZ015666 for 21 days each significantly reduced tumor volume vs. vehicle-treated controls (p<0.0001 for all). Data wer...